evaluationofclinicalmethodsforrating dyspnea* · dyspnea, only patients who werenottaking...

7
580 Clinical Methods for Rating Dyspnea (Mahlei Wells) Evaluation of Clinical Methods for Rating Dyspnea* Donald A Mahier, M.D. FC.C.P; t and Carolyn K. Wells, M.PH.1 To evaluate available clinical methods (self ratings and questionnaire) for rating dyspnea, we (1) compared scores from the recently developed baseline dyspnea index (BDI) with the Medical Research Council (MRC) scale and the oxygen-cost diagram (OCD) in 133 patients with various respiratory diseases who sought medical care for shortness of breath; and (2) evaluated the relationships between dyspnea scores and standard measures of physiologic lung function in the same patients. The dyspnea scores were all significantly correlated (r=O.48 to 0.70; p<O.OOl). Agree- ment between two observers or with repeated use was satis- factory with all three clinical rating methods. The BDI showed the highest correlations with physiologic measure- D yspnea, especially on physical exertion, is a pre- dominant complaint of patients with respiratory disease, and is often the reason that a person seeks medical attention. The experience of difficult or un- comfbrtable breathing is probably the single most important factor that limits that person’s ability to function on a day-to-day basis. Despite the frequency ofdyspnea, the mechanisms contributing to the sensa- tion ofbreathlessness are poorly understood. Although the perception of dyspnea can be evaluated in the laboratory using psychophysical techniques,”2 we be- lieve that the symptom of breathlessness, defined as “difficult or labored breathing,” should be considered as the sum of physiologic and psychologic factors that affect a patient’s functional health status. Therefore, it is useful to measure or quantify this symptom so that its severity can be assessed and response to specific therapy can be determined.’ The purpose ofthis study was twofold: (1) to compare the existing clinical techniques fur grading dyspnea; and (2) to correlate these instruments with standard physiologic measurements in a large group of sympto- matic patients. We were especially interested to evalu- ate the recently developed baseline dyspnea index,7 6From the Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire, and the Department ofMedicine, Yale University School of Medicine, New Haven, Conn. tAssociate Professor of Medicine, Dartmouth Medical School. Recipieng of a Pulmonary Academic Award from the National Heart, Lung, and Blood Institute. llnsfructor in Medicine, Yale University School of Medicine. This study was supported by grants from the National Institutes of Health (BRSG), the New Hampshire Affiliate of the American Heart Association, the Andrew W. Mellon Foundation, and the Commonwealth Fund (81-24). Manuscript received August 25; revision September 29. Reprint requests: Dt Mahier, Pulmonary Section/Medicine, Dartmouth Medical School, Hanover, NH 03756 ments. Dyspnea scores were most highly related to spiro- metric values (r0.78; p<O,00l) for patients with asthma, niaidmal respiratory pressures (r=O.34 and 0.35; p<O.OO1) for patients with chronic obstructive pulmonary disease, and Plmax (r=O.51 p=O.Ol) and FYC (r=O.44; p=O.03) for those with interstitial lung disease. These results show that: (1)the BDI, MRC scale, and OCD provide significantly related measures of dyspnea; (2) the dinical ratings of dyspnea correlate significantly with physiologic parameters oflungfunction; and(3)breathlessness maybe related to the pathophysiology of the specific respiratory disease. The clinical ratingofdyspnea mayprovide quantitative informa- lion complementary to measurements of lung function, which provides a multidimensional rating of breath- lessness, with previously described approaches fur quantifying breathlessness in patients with a wide spectrum of disease severity. Patients with diverse cardiorespiratory conditions were studied including chronic obstructive pulmonary disease (COPD), in- terstitial lung disease (ILD), asthma, heart disease, and obesity. This mnfbrmation has potential application in the care ofpatients who experience breathlessness, because this symptom can greatly influence an individ- ual’s overall health status. lbtient Population MATERIAL AND METHODS One hundred sixty-one patients, all of whom had the chief complaint ofbreathlessness, were evaluated. Subjects were referred to the pulmonary function laboratory of the Dartmouth-Hitchcock Medical Center for investigation ofdyspnea by their physicians. To avoid the potential influence of medications on the ratings of dyspnea, only patients who were not taking any cardiorespiratory drugs for atleast 48 hours were included. Appropriate subjects were studied in consecutive order between May 1983 and August 1985. The study was approved by the Institutional Review Board, and informed consent was obtained. In 153 patients, a specific disease was established as the primary cause of dyspnea. This information was obtained by reviewing the patient medical record afterappropriate tests had been completed. These 153 subjects are the focus of this investigation. In eight patients, the reason for shortness ofbreath was not established, and they were excluded. Rating of Dyspnea Three different clinical methods were used for rating dyspnea at a single point in time: a modification of the scale devised by the Medical Research Council of Great Britain5 (Appendix A); the oxygen-cost diagram5(Appendix B); and the baseline dyspnea index7 (Appendix C). The modified MRC method is a five-point scale based on degrees Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Upload: vudat

Post on 10-Aug-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

580 Clinical Methods for Rating Dyspnea (Mahlei Wells)

Evaluation of Clinical Methods for RatingDyspnea*Donald A Mahier, M.D. FC.C.P; t and Carolyn K. Wells, M.PH.1

To evaluate available clinical methods (self ratings andquestionnaire) for rating dyspnea, we (1) compared scores

from the recently developed baseline dyspnea index (BDI)

with the Medical Research Council (MRC) scale and theoxygen-cost diagram (OCD) in 133 patients with various

respiratory diseases who sought medical care for shortnessof breath; and (2) evaluated the relationships between

dyspnea scores and standard measures of physiologic lung

function in the same patients. The dyspnea scores were all

significantly correlated (r=O.48 to 0.70; p<O.OOl). Agree-ment between two observers or with repeated use was satis-factory with all three clinical rating methods. The BDIshowed the highest correlations with physiologic measure-

D yspnea, especially on physical exertion, is a pre-

dominant complaint of patients with respiratory

disease, and is often the reason that a person seeks

medical attention. The experience of difficult or un-

comfbrtable breathing is probably the single most

important factor that limits that person’s ability to

function on a day-to-day basis. Despite the frequency

ofdyspnea, the mechanisms contributing to the sensa-

tion ofbreathlessness are poorly understood. Although

the perception of dyspnea can be evaluated in the

laboratory using psychophysical techniques,”2 we be-

lieve that the symptom of breathlessness, defined as

“difficult or labored breathing,”� should be considered

as the sum of physiologic and psychologic factors that

affect a patient’s functional health status. Therefore, it

is useful to measure or quantify this symptom so that its

severity can be assessed and response to specific

therapy can be determined.’�

The purpose ofthis study was twofold: (1) to compare

the existing clinical techniques fur grading dyspnea;

and (2) to correlate these instruments with standard

physiologic measurements in a large group of sympto-

matic patients. We were especially interested to evalu-

ate the recently developed baseline dyspnea index,7

6From the Department of Medicine, Dartmouth Medical School,

Hanover, New Hampshire, and the Department ofMedicine, YaleUniversity School of Medicine, New Haven, Conn.

tAssociate Professor of Medicine, Dartmouth Medical School.Recipieng of a Pulmonary Academic Award from the NationalHeart, Lung, and Blood Institute.

llnsfructor in Medicine, Yale University School of Medicine.This study was supported by grants from the National Institutes ofHealth (BRSG), the New Hampshire Affiliate of the AmericanHeart Association, the Andrew W. Mellon Foundation, and theCommonwealth Fund (81-24).

Manuscript received August 25; revision September 29.Reprint requests: Dt� Mahier, Pulmonary Section/Medicine,Dartmouth Medical School, Hanover, NH 03756

ments. Dyspnea scores were most highly related to spiro-metric values (r0.78; p<O,00l) for patients with asthma,

niaidmal respiratory pressures (r=O.34 and 0.35; p<O.OO1)

for patients with chronic obstructive pulmonary disease,and Plmax (r=O.51 p=O.Ol) and FYC (r=O.44; p=O.03)

for those with interstitial lung disease. These results showthat: (1)the BDI, MRC scale, and OCD provide significantlyrelated measures of dyspnea; (2) the dinical ratings ofdyspnea correlate significantly with physiologic parameters

oflungfunction; and(3)breathlessness maybe related to the

pathophysiology of the specific respiratory disease. Theclinical ratingofdyspnea mayprovide quantitative informa-

lion complementary to measurements of lung function,

which provides a multidimensional rating of breath-

lessness, with previously described approaches fur

quantifying breathlessness in patients with a wide

spectrum of disease severity. Patients with diverse

cardiorespiratory conditions were studied including

chronic obstructive pulmonary disease (COPD), in-

terstitial lung disease (ILD), asthma, heart disease,

and obesity. This mnfbrmation has potential applicationin the care ofpatients who experience breathlessness,

because this symptom can greatly influence an individ-

ual’s overall health status.

lbtient Population

MATERIAL AND METHODS

One hundred sixty-one patients, all of whom had the chiefcomplaint ofbreathlessness, were evaluated. Subjects were referredto the pulmonary function laboratory of the Dartmouth-HitchcockMedical Center for investigation ofdyspnea by their physicians. Toavoid the potential influence of medications on the ratings ofdyspnea, only patients who were not taking any cardiorespiratorydrugs for atleast 48 hours were included. Appropriate subjects were

studied in consecutive order between May 1983 and August 1985.The study was approved by the Institutional Review Board, andinformed consent was obtained.

In 153 patients, a specific disease was established as the primarycause of dyspnea. This information was obtained by reviewing thepatient� medical record afterappropriate tests had been completed.These 153 subjects are the focus of this investigation. In eightpatients, the reason for shortness ofbreath was not established, andthey were excluded.

Rating of Dyspnea

Three different clinical methods were used for rating dyspnea at asingle point in time: a modification of the scale devised by the

Medical Research Council of Great Britain5 (Appendix A); theoxygen-cost diagram5(Appendix B); and the baseline dyspnea index7

(Appendix C).The modified MRC method is a five-point scale based on degrees

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Page 2: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

CHEST I 93 I 3 I MARCH, 1988 581

ofvarious physical activities that precipitate breathlessness.8 In ourstudy, each patient was instructed to read the descriptive statementsand then select the numberwhich best fitted his shortness of breath.The MRC scale was completed within 30 seconds.

The oxygen-cost diagram is avisual analog scale consistingofa line100 mm longwith descriptive phrases at various points along the line

which correspond to oxygen requirements of different activities.’

The top ofthe vertical line represents “no breathlessness,” while thebottom ofthe line reflects “the greatest breathlessness.” The patientwas instructed to “mark the line at a point above which you wouldbecome breathless.” Usually, further explanation was necessary for

the patient to understand the relationship between the vertical lineand the listed activities. The distance from the bottom ofthe scale to

the patient’s mark was measured in millimeters and provided a

quantification ofthe subject’s dyspnea. It took one to two minutes forthe patient to complete the OCD.

The baseline dyspnea index consists offive specific grades for eachofthree categories: ftmctional impairment, magnitude oftask, and

magnitude of efl�rt.7 To grade dyspnea with the BDI, an observerinterviewed the patientand asked open-ended questions concerningthe patient’s symptoms. The observer then focused on specificcriteria for the severity ofbreathlessness in each category as outlinedin the BDI. Based on the patient’s responses, the observer was ableto grade the degree ofimpairment (range, 0 to 4) related to dyspneafor all three components. A baseline focal score was obtained by

adding the three ratings for functional impairment, magnitude of

task, and magnitude ofeffort. The range for the focal score was 0 to12. The interviewing process took two to three minutes.

The MRC, OCD, and BDI methodswere administered in random

ordertoall patients by one oftwo pulmonary technicians priorto anypulmonary function testing. In addition, one of the authors(D.A.M.), a pulmonary physician, peiformed similar ratings usingthe MRC scale in 25 patients and the OCD and BDI in 57 ofthe 153patients. This was done either before or after the evaluation by the

technician.

Physiologic Measurements

Physiologic testing was completed on the same day as dyspnea was

graded. Forced vital capacity(FVC)and forced expiratory volume in

one second (FEy,) were measured in the seated position using theGould M100B testing system. Values were selected from the best ofthree efforts having the greatest sum ofFVC and FEV,.’#{176}Predictednormal values were taken from Morris et al.11

Maximal inspiratory (Plmax) and expiratory (PEmax) mouthpressure were measured using the system described by Black andHyatt” Plmax was determined at residual volume, while PEmax

was obtained at total lung capacity. The highest ofthree efl�rts was

selected for Plmax and PEmax, and predicted normal values were

taken from Black and Hyatt’s

Statistical Analysis

Correlations between dimensional variables were evaluated usingPearson’s correlation coefficient (r). Additional correlations wereperformed between ordinal variables using Kendaffs tau and be-

tween ordinal and dimensional variables using Jaspen’s multiserialcorrelation coefficient. Although these additional statistical methodsare considered more appropriate for analysis ofrelationships involv-ing ranked � the values for these correlations are comparable toPearson’s correlation coefficients. For example, the association

between FEV, and the MRC ratings was -0.46 for Jaspen’s r(p<0.0001) compared to -0.41 for Pearson’s r (p<0.0001). There-fore, we have chosen to present all results as Pearson’s correlationcoefficient for ease in comprehension and comparison across rela-

tionships. The ratings obtained by the pulmonary technicians wereused for all calculations.

The ability ofthe patient to select the same integer, 0 to 4, on twoapplications of the MRC scale and agreement between one of the

pulmonary technicians and the physician for the BDI, 0 to 12, were

determined using both weighted percentage agreement andweighted kappa (,#{231}).’�”Since the dyspnea scores are ranked as

integers, the percentage ofagreement was calculated after weightswere assigned to disparities among categories; values for percentageagreement can range from 0 to 100 percent.’� The #{231}statistic

provides for disparities in ranks and also adjusts for the amount ofagreement that mightoccurbychance.WValues for i#{231}canrange from- 1 (total disagreement) to + 1 (perfect agreement); a value of 0

represents agreement expected by chance.Since the OCD is a dimensional ranking system, the intraclass

correlation coefficient was calculated to assess agreement betweentwo repeated efforts by the patient using the OCD.#{176}

Difl�rences in correlations between ratings ofdyspnea (modified

MRC, OCD, and BDI) and measures of lung function for thedifferent diseases (COPD, ILD, and asthma) were assessed using astandard statistical test.”

Values are reported as mean ± SD.

RESULTS

The patients consisted of 97 men and 56 women.

Age was 57 ± 15 years. Specific conditions and number

ofsubjects fur each subgroup include: COPD, 91; ILD,

23; asthma, 17; heart disease, 9; obesity, 6; and

miscellaneous, 7 (cystic fibrosis, chest wall abnormali-

ties, and respiratory muscle weakness). Physiologic

function and dyspnea ratings fur the groups of subjects

are shown in ‘J1�ble 1. The range of scores fur the

dyspnea ratings indicates the wide spectrum of sever-

ity in this patient group, from no detectable impair-

ment (OCD, 100 mm, 2 patients; MRC, grade 0, 18

patients; BDI, grade 12, 4 patients) to severe impair-

ment (OCD, 1 mm, 1 patient; MRC, grade 4, 5

patients; BDI, grade 0, 3 patients).

Scores fur the specffic components of the BDI are

shown in Table 2. Although the largest number of

patients had only slight impairment, grade 3, fur the

functional component, a majority showed moderate

impairment, grade 2, fur magnitude of task, and

ranged from light to major impairment fur efibrt.

Observer agreement between the pulmonary tech-

nician and the pulmonary physician fur the MRC scale

and BDI are described in ‘Jlible 3. Agreement was

extremely high for the MRC scale, since the patient

selected one offive possible categories as requested by

two different interviewers. Weighted percentage

agreement fur the BDI exceeded 90 percent fur the

three components as well as the fucal score, while

values fur ,#{231}ranged from 0.66 (magnitude ofeffort) to

0. 73 (functional impairment), representing substantial

agreement between the two observers using the BDI. ‘�

The intraclass correlation coefficient for the OCD was

0.68; a value of 0.70 is considered to reflect good

agreement. ‘�

Relationships among the three clinical methods for

rating dyspnea are depicted in 11�ble 4. The modified

MRC scale, OCD, and BDI were all signfficantly

interrelated. The magnitude oftask component fur the

BDI showed slightly greater correlation with the MRC

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Page 3: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

Table 1-Physiologk Function and Dyspnea Ratings in Patients Evaluatedfor Breathlessness*

582 Clinical Methods for Rating Dyspnea (MaNei Wells)

HeartCOPD

Measurement (n = 91)

ILD

(n = 23)Asthma

(n = 17)

Disease

(n = 9)

Obesity

(n = 6)

Miscellaneous

(n = 7)Total

(n = 153)

Physiologic function, mean ± SD (%)

FVC,L 3.19±1.10 2.68±0.90 3.74±1.58 3.50±0.80 3.06±1.07 2.49±0.66 3.15±1.13

(79± 20) (70± 18) (92±27) (91 ± 14) (94 ± 14) (59 ± 17) (80± 21)

FEV,, L 1.64±0.73 2.02±0.73 2.70±1.26 2.60±0.60 2.34±1.05 1.80±0.61 1.91±0.88

(58 ± 22) (71 ± 19) (86± 30) (94 ± 13) (96±31) (56± 18) (67± 26)

Plmax,cmH,O 93±31 99±37 196±34 99±34 88±34 87±36 96±32

(96±30) (196±40) (99±31) (106±26) (109±42) (53±33) (98±32)PEmax,cmH,O 143±49 127±44 151±53 141±51 132±46 140±58 141±49

(77± 25) (72 ± 21) (79± 18) (78 ± 22) (86± 24) (69 ± 22) (77± 23)Dyspnea ratingst (median, range)

MRC 1 (0-4) 1 (0-4) 1 (0-3) 1 (0-3) 1 (1-3) 2 (0-4) 1 (0-4)

OCD 55 (1-94) 56 (0-96) 60 (0-03) 63 (27-76) 44 (7-68) 56 (24-81) 55 (0-96)

BDI 6 (0-12) 7 (3-12) 7 (2-12) 7 (3-8) 6 (2-7) 7 (2-11) 7 (0-12)

‘FVC = forced vital capacity, FEy, = forced expiratory volume in one second, Plmax= maximal inspiratory pressure; PEmax = maximal

expiratory pressure; MRC modified Medical Research Council scale;’ OCD Oxygen-cost diagram;9 BDI Baseline dyspnea index;7 andnumber in parentheses under physiologic function represents percent of predicted value.

tBased on ratings obtained by a pulmonary technician.

scale, whereas all three components of the BDI had

similar correlations with the OCD. However, the focal

dyspnea score provided greater correlations with the

two other methods of grading dyspnea than any of the

three single components of the BDI.

Correlations among dyspnea scores and measures of

respiratory function are shown in Table 5. Ratings from

the BDI and the MRC scale showed comparable

associations with FYC and FEY, which were higher

and more significant than those observed with the

OCD. However, the BDI demonstrated slightly higher

correlations with Plmax and PEmax than either the

MRC scale or the OCD.

The relationships among respiratory function and

the BDI for three major disease categories are pre-

sented in Figure 1. In COPD, the PEmax (r=0.35;

p<O.OOl) and Plmax (r = 0.34; p<O.OOl) showed the

greatest correlations with the clinical rating for dysp-

nea. In patients with asthma, FYC (r = 0. 78; p <0.001)and FEY, (r0.77; p <0.001) were highly related to

the BDI. For interstitial lung disease, only Plmax

(r = 0.51; p = 0.01) and FYC (r 0.44; p 0.03) showed

Table 2-.Scoresfor Components ofthe Baseline Dyspnea

index

Component

Scores4

0 1 2 3 4

Functional 18 17 40 62 16

impairment

Magnitude 3 29 87 25 9

of taskMagnitude 3 49 62 31 8

of effort

‘Numbers refer to number of patients who had the corresponding

score for the specific compou.ents of the baseline dyspnea index.

significant correlations with breathlessness.

Comparisons of the correlations for lung function

and dyspnea ratings among the three diseases revealed

that r values were significantly higher for FYC (test

statistic = - 2. 66; p<0. 01) and FEY, (test statis-

tic = - 2.44; p<O. 05) between COPD and asthma with

the BDI. Similar analyses fur the MRC scale and OCD

showed no significant differences fur correlation coeffi-

cients across diseases.

DISCUSSION

We believe that the clinical measurement of dyspnea

is important fur several reasons. First, breathlessness

is frequently the patient’s major complaint. Second, as

a symptom, breathlessness represents the summation

of pathophysiologic and psychologic factors which

collectively provide a distressing signal to the patient.

By quantifying dyspnea, the physician can assess its

severity and its impact on a person’s functional health

status. Third, and probably most important, grading

dyspnea is an important consideration for establishing

Table 3-interobaerver Agreement in Ratings of Dyspnea*

Weighted

Component

No. of

RatingsPercentage

Agreement s#{231}

MRC 25 98 0.92

BDIFunctional impairment 56t 91 0.73

Magnitude of task 57 93 0.68Magnitude of efibrt 57 91 0.66Baseline focal score 56t 99 0.72

‘MRC = modified Medical Research Councilscale;’ BDI baseline

dyspnea index.7

tOne patient was rated as “amount uncertain” for functional impair-ment.

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Page 4: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

CHEST I 93 I 3 I MARCH, 1988 583

Table 4-Correlations Among Three Clinical Methods forRating Dyapnea�

Method MRC OCD

MRC(n=153) - -0.53

OCD(n=153) -0.53 -

BDI (n=153)Functional impairment -0.61 0.50

Magnitude oftask -0.67 0.50

Magnitude ofeffort -0.64 0.48

Focaiscore -0.70 0.54

‘MRC = modified Medical Research Council scale;’ OCD oxygencost diagram;’ BDI baseline dyspnea index.7- Values represent Pearson�s correlation coefficients; all rela-tionships are statistically significant with p<0.OOL

efficacy oftreatment. At present, there is no objective

evidence that any pharmacologic therapy, except oxy-

gen,’7 prolongs survival or alters the decline in lung

function in chronic respiratory disorders.” There-

fure, treatment should be directed toward improving

symptoms such as dyspnea.

To evaluate available clinical methods fur rating

dyspnea, we compared the BDI, MRC scale, and

OCD in a large number of patients with diverse

cardiorespiratory diseases and a wide spectrum of

physiologic severity. We were especially interested in

comparing the recently devised baseline dyspnea

index,7 which includes the components of functional

impairment and magnitude of effort affecting

breathlessness along with the magnitude oftask, with

previously described methods, such as the MRC scale’

and the OCD,’ which are based exclusively on per-

furmance ofphysical tasks. This present study expands

our initial experience with the BDI7 to include 153

additional subjects complaining of breathlessness due

to a variety of difl�rent causes.

Dyspnea scores from all three methods were signifi-

cantly correlated gable 4). Cuyatt et al� also showed

significant correlation between the BDI and OCD

(r, = 0.59; p = 0.001) in 25 patients with COPD. How-

ever, examination of the specffic scores fur each of the

three components of the BDI demonstrates consider-

able differences (Table 2). For example, a patient may

require extraordinary eflbrt to accomplish a relatively

easy task, and the corresponding ratings fur these

components ofthe BDI would be distinctly different.Also, the demands of an individual task may have

totally diffi�rent consequences depending on a person’s

activities at work and/or home. For these reasons,

measurement of specific components affecting dysp-

nea appears to be important. In further support of this

approach, Stoller et ala’ concluded that each of the

components of a modified BDI makes a distinctive

contribution to the measurement ofdyspnea. Prospec-

tive application and analysis ofthe specffic components

of the BDI would be useful to further evaluate this

multidimensional clinical tool.

Observer agreement was satisfactory fur each of the

three different clinical methods. Agreement for the

MRC scale was nearly perfect, as would be expected

when an individual patient is asked to grade his degree

of breathlessness on two occasions on the same day

using a five-point global scale. Agreement fur the

OCD, administered in the same fashion, was accepta-

ble, although some patients had initial difficulty under-

standing how to use this scale. On the other hand, theBDI was used by two different interviewers to rate

dyspnea according to responses of the patient to

specffic questions. Despite this added dimension of

potential variability, both the percentage agreement

and #{231},statistics showed substantial agreement be-

tween observers. These results are comparable to

previous experience with the baseline dyspnea index

in a smaller number of subjects, all of whom had

COPD.7

Dyspnea scores obtained from the MRC scale,

OCD, and BDI correlated significantly with lung

function and respiratory muscle strength (Table 5).

However, the BDI and MRC scale showed substan-

tially higher correlations with spirometric values than

did the OCD, while the BDI had the highest correla-

tions with Plmax and PEmax. These relationships

appear to be consistent with our understanding of the

sensation of dyspnea, which is related to map-

propriateness between lung volume and muscular

output (length and tension) of the respiratory mus-

des.

The lbcal dyspnea score from the BDI showed

various correlations with physiologic parameters de-

pending on the disease category (Fig 1). However,

analyses showed statistical differences fur only FVC

and FEY, between patients with asthma and COPD.

In contrast, there were no significant differences using

the MRC scale or OCD across disease categories.

These data suggest that different pathophysiologic

processes may be important in generating or contrib-

uting to the symptom of dyspnea at least between

asthma and COPD. Additional numbers of patients

might be necessary to demonstrate other diffi�rences

Table 5-Correlations Among Dyspnea Scores and

Measures ofReapiratory 1lanCtiOn�

DyspneaScores FVC FEV, Plmax PEmax

MRC -0.41(<0.001)

-0.42(<0.001)

-0.38(<0.001)

-0.29(<0.001)

OCD 0.16(0.06)

0.16(0.04)

0.28(<0.001)

0.25(0.002)

BDI 0.41

(<0.001)0.43(<0.001)

0.43(<0.001)

0.36(<0.001)

‘Values represent Pearson�s correlation coefficients. Corresponding

p values are in parentheses.

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Page 5: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

I .0 copo(n:91)

ASTHMA(�: I 7)

C-,

0C-)

0

0

0C-)

(-)>)()( C_)>_)(*>w’�< �,w<’� >w�LA�L9�� �

�LLJ ,-,w �L&J

Q_a_ Q_o_ a_o_

FIGURE 1. Correlations among respiratory function and baseline

dyspnea index for three major categories. COPD = chronic obstruc-tive pulmonary disease; ILD interstitial pulmonary disease.

Appendix A-Modified Medical Research Council DyspneaSCa1e

4From Br Med J 1978; 2:241-43.

584 Clln�caI Methods for Rating Dyspnea (Mahler, Wells)

fur specific diseases.

We believe that the clinical measurement of dyspnea

has wide potential application in the practice of medi-

cine. The measurement process is reproducible and

can be completed in less than five minutes. The cost is

minimal, and a nurse, respiratory therapist, pulmo-

nary technician, or physician can grade the severity of

a patient’s breathlessness. In fact, ratings ofdyspnea by

nonphysicians may be more accurate than those by

physicians, since the patient may be less likely to be

influenced by any expectations that the physician may

have or express.

Evaluation of dyspnea is also an important consid-

eration in establishing benefits of therapy. Since no

data demonstrate that pharmacologic therapy, except

oxygen,’7 reduces mortality or retards the decline in

lung function in patients with respiratory disease,”

the primary goal of treatment should be to alleviate

symptoms, such as dyspnea, and to improve functional

capacity. Previous studies have demonstrated the ap-

plication and utility ofa visual analog scale and the BDI

fur rating dyspnea in documenting improvement in

breathlessness.� Because the MRC scale, which con-

thins five grades, may be too coarse to demonstrate

distinct changes, we believe that a visual analog scale,

such as the OCD,’ or the transition dyspnea index,7

which has been shown to reliably denote changes from

the baseline condition,5 is most appropriate fur statis-

tied comparisons of response to therapy.

This study directly compared the BDI, a modified

MRC scale, and the OCD fur measuring dyspnea in

153 patients with breathlessness due to a spectrum of

cardiopulmonary disorders. The three different ap-

ILD proaches were all significantly interrelated. Agree-( n �23) ment was highly satisfactory for the BDI and MRC and

acceptable fur the OCD. Ratings from all three meth-

ods correlated significantly with measurements of lung

function and respiratory muscle strength. However,

differences among correlations were observed only fur

the BDI between asthma and COPD. Our results

demonstrate that the clinical rating of dyspnea pro-

vides quantitative information which is complemen-

tary to physiologic testing. We believe that the mea-

surement of dyspnea can be useful in the evaluation

and treatment of affected patients.

ACKNOWLEDGMENT: The authors thank T. Lentine andj. Wardfor their technical assistance and for applying the clinical methods tograde dyspnea in this study.

Grade Description

0 Not troubled with breathlessness except with strenuousexercise

1 ‘froubled by shortness ofbreath when hurrying on the

level or walking up a slight hill2 WalkS slower than people ofthe same age on the level

because of breathlessness or has to stop for breathwhen walking at own pace on the level

3 Stops for breath after walking about 100 yards or after a

few minutes on the level4 Too breathless to leave the house or breathless when

dressing or undressing

4From ATS News 1982; 8:12-16.’

APPENDIX B

OXYGEN-COST DIAGRAM

brisk walking uphill

medium walking uphill

I brisk walking on the level

slow walking uphill ) heavy shopping

bedmaking medium walking

I light shoppingwashing yourself slow walking on the level

sitting standing

sleeping

0

9

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Page 6: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

Functional Impairment ____ Grade 2:

APPENDIX C-Baseline Dyspnea 1ndex� the task requires extraordinary effort thatmay be performed with pauses.

Moderate. Becomes short of breath with

Grade 4: No Impairment. Able to carry out usual moderate effort. Tasks performed with occa-

activities and occupation without shortness sional pauses and requiring longer to corn-ofbreath. plete than the average person.

Grade 3: Slightlmpairment. Distinct impairment in at Grade 1: Light. Becomes short of breath with littleleast one activity but no activities completely effort. Thsks performed with little effort or

abandoned. Reduction, in activity at work or more difficult tasks performed with frequent

in usual activities, that seems slight or not pauses and requiring5o-100% longer to corn-

clearly caused by shortness ofbreath. plete than the average person might require.Grade 2: Moderate Impairment. Patient has changed Grade 0: No effort. Becomes short of breath at rest,

jobs andlor has abandoned at least one usual while sitting, or lying down.

activity due to shortness ofbreath. W: Amount Uncertain. Patient’s exertional abil-

Grade 1: Severe Impairment. Patient unable to work ity is impaired due to shortness ofbreath, butor has given up most or all usual activities amount cannot be specified. Details are not

due to shortness of breath. suflicient to allow impairment to be catego-Grade 0: Very Severelmpairment. Unable toworkand rized.

has given up most ofall usual activities due to X: Unknown. Information unavailable regard-shortness of breath. ing limitation of eflbrt.

W: Amount Uncertain. Patient is impaired due Y: lmpairedfor Reasons Other than Shortnessto shortness ofbreath, but amount cannot be of Breath. For example, musculoskeletalspecified. Details are not sufficient to allow

impairment to be categorized.. .

X: UnKnown: Inxormat:on unavanao:e regara-

problems or chest pain.7

4From Chest 1984; 85:751-58.

ing impairment.

Y: Impairedfor Reasons Other than Shortness

of Breath. For example, musculoskeletal REFERENCESproblem or chest pain.

Usual activities refer to requirements ofdaily living, maintenance

or upkeep ofresidence, yard work, gardening, shopping, etc.

B�ers JHCM, Tenney SM. The perception of some sensations

associated with breathing. Respir Physiol 1970; 10:85-92

2 � KJ, MabuU�e CK, Campbell EJM. Magnitude scaling ofMagnitude ofTask externally added loads to breathing. Am Rev Respir Dis 1981;

Grade 4: Extraordinary. Becomes short ofbreath only 123:12-15with extraordinary activity such as carrying 3 Dorland’s Illustrated Medical Dictionary, 25th ed Philadelphia:very heavy loads on the level, lighter loads WB Saunders, 1981:414uphill, or running. No shortness of breath 4 WoodcockAA, Gross ER, Gellert A, Shah 5, Johnson M, Geddeswith ordinary tasks. DM. Effects of dihydrocodeine, alcohol, and caffeine on

Grade 3: Majo, Becomes short of breath only with breathlessness and exercise tolerance in patients with chronicmajor activities as walking up a steep hill, obstructive lung disease and normal blood gases.

climbing more than three flights ofstairs, or N EngI J Med 1981; 305:1611-16carrying a moderate load on the level. 5 Mahler DA, Matthay BA, Snyder PE, Wells CK, Loke J.

Grade 2: Moderate. Becomes short of breath with Sustained-release theophylline reduces dyspnea in nonreversi-moderate or average tasks such as walking up ble obstructive airway disease. Am Rev Respir Dis 1985; 131:a gradual hill, cimbingless than three flights 22-25ofstairs, or carrying a light load on the level. 6 Dullinger D, Kronenberg R, Niewoehner DE. Efficacy in

Grade 1: Light. Becomes short of breath with light inhaled metaproterenol and orally-administered theophylline inactivities such as walking on the level, wash- patients with chronic airflow obstruction. Chest 1986; 89:171-73ing, or standing. 7 Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The

Grade 0: No Task. Becomes short of breath at rest, measurement of dyspnea: contents, interobserver agreement,while sitting, or lying down. and physiologic correlates of two new clinical Indexes. Chest

W: Amount Uncertain. Patient’s ability to per- 1984; 85:751-58form tasks is impaired due to shortness of 8 Task group on surveillance for respiratory hazards in the occupa-

breath, but amount cannot be specified. tional setting, Brooks SM (Chairman). Surveillance for respira-Details are not sufficient toallow impairment tory hazards. ATS News 1982; 8:12-16to be categorized. 9 McGavin CR, Artvinli M, Naoe H, McHardy GJR. Dyspnea,

X: Unknown. Inlbrmation unavailable regard- disability, and distance walked: comparison of estimates of

ing limitation of magnitude or task. exercise performange in respiratory disease. Br Med J 1978; 2:

Y: lmpairedfor Reasons Other than Shortness 241-43of Breath. For example, musculoskeletal 10 Gardner RM. Snowbird workshopon standardization of spirome-problem or chest pain. try. Am Rev Respir Dis 1979; 119:831-38

Magnitude ofEffort 11 Morris JF, Koski A, Johnson LC. Spirometric standards forGrade 4: Extraordinari� Becomes short ofbreath only healthy nonsmoking adults. Am Rev Respir Dis 1971; 103:57-67

withthegreatestimagmableeffort. Noshort- 12 Black LF, Hyatt RE. Maximal respiratory pressures: normalness of breath with ordinary effort. values and relationships to age and sex. Am Rev Respir Dis 1969;

Grade 3: Major Becomes short of breath with effort 99:696-702distinctly submaximal, but of major propor- 13 Freeman LC. Elementary applied statistics. New York: Wiley,tion. Th,sks performed without pause unless 1965.

CHEST/93/3/MARCH,1988 585

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017

Page 7: EvaluationofClinicalMethodsforRating Dyspnea* · dyspnea, only patients who werenottaking anycardiorespiratory drugsforatleast 48hourswereincluded. Appropriate subjects were studied

Continuing Problems in Critical CareThe Johns Hopkins Medical Institutions willpresent this medical education program May 9-10

at the Sheraton Inner Harbor Hotel, Baltimore. For infbrmation, contact Ms. Pamela E.Macedonia, Program Coordinator, Office ofContinuing Education, The Johns Hopkins Medical

Institutions, Turner 22, 720 Rutland Avenue, Baltimore 21205 (301:955-6085).

588 cIin�ca1 Methods or Rating Dyspnea (M&We� VvWls)

14 Kramer MS. Feinstein AR. Clinical biostatistics: LIV. The

biostatistics ofconcordance. Cliii Pharm Ther 1981; 29:111-2315 Landis RJ, Koch CC. The measurement ofobserver agreement

for categorical data. Biometrics 1977; 33:159-74

16 Snedecor GW, Cochran WG. Statistical methods, 6th ed. Ames,Iowa: Iowa State University Press, 1967:185-86

17 Nocturnal Oxygen Therapy Thai Group� Continuous or noctur-

nal oxygen therapy in hypoxemic chronic obstructive lungdisease. Ann Intern Med 1980; 93:391-98

18 Emirgil C, Sobol BJ, Norman J, Moskowitz E, Goyal P, Wadh-wani B. A study of the long-term efl�ct of therapy in chronic

obstructive pulmonary disease. Am J Med 1969; 47:367-7719 Burrows B, Earle RH. Course and prognosis ofchronic obstruc-

tive lung disease. N Engl J Med 1969; 280:397-404

20 Guyaft GH, Thompson PJ, Berman LB. Sullivan MJ, Townsend

M, Jones NL, et al. How should we measure function in patientswithchronicheartandlangdisease?J Chron Dis 1985; 38:517-24

21 Stoller JK, Ferranti R, Feinstein AR. Further specifications of a

new clinical index for dyspnea. Am Rev Respir Dis 1986; 134:

11294422 Campbell EJM, HowellJBL. The sensation ofbreathlessness. Br

Med Bull 1963; 19:36-4023 Campbell EJM. The relationships of the sensation of

breathlessness to the actofbreathing. In: HowellJBL, CampbellEJM, eds. Breathlessness. Philadelphia: FA Davis, 1966:55-63

Downloaded From: http://journal.publications.chestnet.org/pdfaccess.ashx?url=/data/journals/chest/21575/ on 06/27/2017